INVESTOR RELATIONS COMPANY PLATFORMS CLINICAL STUDIES CAREERS PUBLICATIONS NEWS CONTACT Stay fully informed. Get the latest news from Brooklyn ImmunoTherapeutics. November 29, 2021 Brooklyn ImmunoTherapeutics Welcomes Susan McClatchey as Vice President and Head of Quality October 14, 2021 Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq September 22, 2021 Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer September 21, 2021 Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021 September 13, 2021 Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET September 9, 2021 Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience August 20, 2021 Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021 August 20, 2021 Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum August 16, 2021 Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Thursday, August 19, 2021 at 4:30 PM ET August 16, 2021 Brooklyn ImmunoTherapeutics Announces Second Quarter 2021 Financial Results 1 2 3 4 5 Privacy Policy Terms of Use © 2021 Brooklyn ImmunoTherapeutics